Swiss National Bank raised its holdings in Analogic Co. (NASDAQ:ALOG) by 7.4% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 21,900 shares of the medical research company’s stock after purchasing an additional 1,500 shares during the quarter. Swiss National Bank owned about 0.18% of Analogic worth $1,834,000 as of its most recent filing with the SEC.
Other hedge funds and other institutional investors have also bought and sold shares of the company. State Street Corp lifted its stake in shares of Analogic by 6.1% during the second quarter. State Street Corp now owns 345,329 shares of the medical research company’s stock valued at $25,086,000 after buying an additional 19,796 shares during the period. Crossmark Global Holdings Inc. purchased a new position in shares of Analogic during the third quarter valued at approximately $250,000. State Board of Administration of Florida Retirement System purchased a new position in shares of Analogic during the third quarter valued at approximately $224,000. American Century Companies Inc. increased its position in Analogic by 18.2% during the third quarter. American Century Companies Inc. now owns 60,063 shares of the medical research company’s stock worth $5,030,000 after purchasing an additional 9,247 shares during the last quarter. Finally, BNP Paribas Arbitrage SA increased its position in Analogic by 50.9% during the third quarter. BNP Paribas Arbitrage SA now owns 6,667 shares of the medical research company’s stock worth $558,000 after purchasing an additional 2,248 shares during the last quarter. Institutional investors own 97.55% of the company’s stock.
Several equities analysts recently commented on the stock. BidaskClub lowered shares of Analogic from a “sell” rating to a “strong sell” rating in a research report on Saturday, January 6th. Zacks Investment Research raised shares of Analogic from a “hold” rating to a “strong-buy” rating and set a $108.00 price target for the company in a research report on Thursday, March 8th. Finally, Jefferies Group reissued a “hold” rating and issued a $80.00 price objective on shares of Analogic in a research report on Friday, December 8th.
Analogic stock traded down $0.30 on Monday, reaching $93.20. 46,841 shares of the company were exchanged, compared to its average volume of 148,309. The firm has a market cap of $1,168.85, a price-to-earnings ratio of -16.09, a price-to-earnings-growth ratio of 3.16 and a beta of 0.77. Analogic Co. has a 1-year low of $66.00 and a 1-year high of $101.80.
Analogic (NASDAQ:ALOG) last posted its quarterly earnings data on Monday, March 5th. The medical research company reported $1.27 EPS for the quarter, beating the Zacks’ consensus estimate of $0.69 by $0.58. Analogic had a negative net margin of 15.34% and a positive return on equity of 6.05%. The firm had revenue of $129.20 million for the quarter, compared to the consensus estimate of $112.50 million. During the same period in the prior year, the firm posted $0.99 EPS. The firm’s revenue was down 1.7% compared to the same quarter last year. sell-side analysts anticipate that Analogic Co. will post 4.23 earnings per share for the current year.
The company also recently disclosed a quarterly dividend, which will be paid on Monday, March 26th. Investors of record on Thursday, March 15th will be given a $0.10 dividend. The ex-dividend date is Wednesday, March 14th. This represents a $0.40 annualized dividend and a yield of 0.43%. Analogic’s dividend payout ratio is presently -6.91%.
WARNING: This report was first posted by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are reading this report on another website, it was stolen and reposted in violation of United States and international copyright & trademark law. The original version of this report can be viewed at https://www.dispatchtribunal.com/2018/03/19/swiss-national-bank-has-1-83-million-stake-in-analogic-co-alog.html.
Analogic Corporation designs, manufactures and commercializes guidance, diagnostic imaging and threat detection technologies. The Company operates through three segments: Medical Imaging, Ultrasound, and Security and Detection. The Company’s Medical Imaging segment provides medical imaging systems and subsystems for computed tomography (CT), magnetic resonance imaging (MRI) and high-resolution digital mammography.
Receive News & Ratings for Analogic Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Analogic and related companies with MarketBeat.com's FREE daily email newsletter.